Skip to content
RDL Network logo
The Effects of Angiotensin Receptor-Neprilysin Inhibition on Major Coronary Events in Patients With Acute Myocardial Infarction: Insights From the PARADISE-MI Trial — Roxana Mehran (2022) | RDL Network